Clinical Trial Update: Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy [Phase 1, Phase 2]

View source ↗

Summary

A Stanford-sponsored Phase 1/2 clinical trial evaluating the cognitive effects of vinpocetine in healthy adults and patients with epilepsy has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Vinpocetine (vinpocetine)

Snippet

Sponsor: Stanford University | Conditions: Epilepsy | Phase 1, Phase 2 | Status: SUSPENDED